These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20660642)

  • 21. A graphical model approach to systematically missing data in meta-analysis of observational studies.
    Kovačić J; Varnai VM
    Stat Med; 2016 Oct; 35(24):4443-4458. PubMed ID: 27311701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The simplest statistical test: how to check for a difference between treatments.
    Pocock SJ
    BMJ; 2006 May; 332(7552):1256-8. PubMed ID: 16735336
    [No Abstract]   [Full Text] [Related]  

  • 23. The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population.
    Lam TH; Liu LJ; Janus ED; Bourke C; Hedley AJ
    Atherosclerosis; 1999 Apr; 143(2):405-13. PubMed ID: 10217371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement error, instrumental variables and corrections for attenuation with applications to meta-analyses.
    Carroll RJ; Stefanski LA
    Stat Med; 1994 Jun; 13(12):1265-82. PubMed ID: 7973207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.
    Wei Y; Royston P; Tierney JF; Parmar MK
    Stat Med; 2015 Sep; 34(21):2881-98. PubMed ID: 26099573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is hypertension the missing link between stress and coronary heart disease?
    Fauvel JP; Ducher M
    Am J Hypertens; 2007 Nov; 20(11):1154-5. PubMed ID: 17954360
    [No Abstract]   [Full Text] [Related]  

  • 27. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
    Smith GD; Harbord R; Milton J; Ebrahim S; Sterne JA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2228-33. PubMed ID: 16123313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Need for more individual-level meta-analyses in social epidemiology: example of job strain and coronary heart disease.
    Kivimäki M; Kawachi I
    Am J Epidemiol; 2013 Jan; 177(1):1-2. PubMed ID: 23144365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis using individual participant data is the gold standard for diagnostic studies.
    Zheng MH; Shi KQ; Fan YC; Chen YP
    Hepatology; 2011 Mar; 53(3):1062; author reply 1062-3. PubMed ID: 21374680
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen, social position, and risk of heart disease.
    Macleod J; Smith GD
    J Epidemiol Community Health; 2004 Feb; 58(2):157. PubMed ID: 14729902
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.
    Barasch E; Benderly M; Graff E; Behar S; Reicher-Reiss H; Caspi A; Pelled B; Reisin L; Roguin N; Goldbourt U
    J Clin Epidemiol; 1995 Jun; 48(6):757-65. PubMed ID: 7769406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.
    de Jong VMT; Moons KGM; Riley RD; Tudur Smith C; Marson AG; Eijkemans MJC; Debray TPA
    Res Synth Methods; 2020 Mar; 11(2):148-168. PubMed ID: 31759339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies.
    Fibrinogen Studies Collaboration
    Stat Med; 2009 Mar; 28(7):1067-92. PubMed ID: 19222086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?
    Davey Smith G; Harbord R; Ebrahim S
    QJM; 2004 Mar; 97(3):163-6. PubMed ID: 14976273
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes.
    Tudur Smith C; Williamson PR
    Clin Trials; 2007; 4(6):621-30. PubMed ID: 18042571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project.
    Jousilahti P; Salomaa V; Rasi V; Vahtera E; Palosuo T
    Atherosclerosis; 2001 Jun; 156(2):451-6. PubMed ID: 11395043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies.
    Danesh J; Peto R
    BMJ; 1998 Apr; 316(7138):1130-2. PubMed ID: 9552950
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrinogen and coronary heart disease--what does it mean?
    Oliver MF
    Eur Heart J; 1998 Jan; 19(1):8-9. PubMed ID: 9503169
    [No Abstract]   [Full Text] [Related]  

  • 40. Retrieval of Individual Participant Data for Exercise Meta-Analyses May Not Be Worth the Time and Effort.
    Kelley GA; Kelley KS
    Biomed Res Int; 2016; 2016():5059041. PubMed ID: 27051665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.